Beijing Tiantan Biological Products Corp. Ltd. (600161) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Beijing Tiantan Biological Products Corp. Ltd.

Why is Beijing Tiantan Biological Products Corp. Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 13.66% and Operating profit at 14.56% over the last 5 years

With a fall in Net Sales of -24.69%, the company declared Very Negative results in Sep 25

OPERATING CASH FLOW(Y) Lowest at CNY -324.97 MM
ROCE(HY) Lowest at 11.91%
DEBT-EQUITY RATIO (HY) Highest at -14.54 %

Below par performance in long term as well as near term

Along with generating -19.97% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Beijing Tiantan Biological Products Corp. Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Beijing Tiantan Biological Products Corp. Ltd.

-35.82%

-2.01

19.25%

China Shanghai Composite

21.43%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

11.15%

EBIT Growth (5y)

7.80%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.20

Sales to Capital Employed (avg)

0.52

Tax Ratio

17.23%

Dividend Payout Ratio

36.25%

Pledged Shares

Institutional Holding

ROCE (avg)

28.16%

ROE (avg)

16.39%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.12

EV to EBIT

14.74

EV to EBITDA

12.11

EV to Capital Employed

2.32

EV to Sales

3.92

PEG Ratio

Dividend Yield

1.64%

ROCE (Latest)

15.77%

ROE (Latest)

11.23%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bullish

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-31What is not working for the Company

ROCE(HY)

Lowest at 8.37%

INTEREST(Q)

At CNY 1.84 MM has Grown at inf%

INTEREST COVERAGE RATIO(Q)

Lowest at 10,676.5

RAW MATERIAL COST(Y)

Grown by 24.31% (YoY

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.97 times

NET SALES(Q)

Lowest at CNY 1,118.2 MM

OPERATING PROFIT(Q)

Lowest at CNY 196.21 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 17.55 %

PRE-TAX PROFIT(Q)

Lowest at CNY 223.22 MM

NET PROFIT(Q)

Lowest at CNY 125.87 MM

EPS(Q)

Lowest at CNY 0.06

Here's what is not working for Beijing Tiantan Biological Products Corp. Ltd.

Net Sales

At CNY 1,118.2 MM has Fallen at -26.89%

over average net sales of the previous four periods of CNY 1,529.39 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Interest

At CNY 1.84 MM has Grown at inf%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 10,676.5

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Pre-Tax Profit

At CNY 223.22 MM has Fallen at -51.01%

over average net sales of the previous four periods of CNY 455.68 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 125.87 MM has Fallen at -53.85%

over average net sales of the previous four periods of CNY 272.71 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Net Sales

Lowest at CNY 1,118.2 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY 196.21 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 17.55 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at CNY 223.22 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Lowest at CNY 125.87 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS

Lowest at CNY 0.06

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Debtors Turnover Ratio

Lowest at 2.97 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 24.31% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Non Operating Income

Highest at CNY 0.13 MM

in the last five periods

MOJO Watch

Increased income from non business activities may not be sustainable

Non Operating income